Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Annals of Internal Medicine
|
May 16, 2007
Narrative review: the pathophysiology of fibromyalgia
Aryeh M Abeles, Michael H Pillinger, Bruce M Solitar, et al.
The American Journal of Medicine
|
July 1, 2008
Update on fibromyalgia therapy
Micha Abeles, Bruce M Solitar, Michael H Pillinger, et al.
Clinics in Dermatology
|
November 23, 2006
Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis
Henry M Feder, Micha Abeles, Megan Bernstein, et al.
Clinical Trials (London, England)
|
December 25, 2009
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study
Vivien M Hsu, Dinesh Khanna, Edwin Smith, et al.
Seminars in Arthritis and Rheumatism
|
February 24, 2004
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned
Philip J Clements, James R Seibold, Daniel E Furst, et al.
Arthritis and Rheumatism
|
November 13, 2002
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial
Paul J DeMarco, Michael H Weisman, James R Seibold, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Annals of Internal Medicine
|
May 16, 2007
Narrative review: the pathophysiology of fibromyalgia
Aryeh M Abeles, Michael H Pillinger, Bruce M Solitar, et al.
The American Journal of Medicine
|
July 1, 2008
Update on fibromyalgia therapy
Micha Abeles, Bruce M Solitar, Michael H Pillinger, et al.
Clinics in Dermatology
|
November 23, 2006
Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis
Henry M Feder, Micha Abeles, Megan Bernstein, et al.
Clinical Trials (London, England)
|
December 25, 2009
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study
Vivien M Hsu, Dinesh Khanna, Edwin Smith, et al.
Seminars in Arthritis and Rheumatism
|
February 24, 2004
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned
Philip J Clements, James R Seibold, Daniel E Furst, et al.
Arthritis and Rheumatism
|
November 13, 2002
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial
Paul J DeMarco, Michael H Weisman, James R Seibold, et al.
Page
of 2